home / openregs / documents

documents: FDA-2016-M-0035-0030

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-M-0035-0030 FDA FDA-2016-M-0035 Reference 28 - Eliminating the Blood Outbreaks of Hepatitis B Virus Infection and the Need for Innovative Glucose Monitoring Technologies re Effective Date of Requirement for Premarket Approval for Blood Lancets Supporting & Related Material Background Material 2016-03-07T05:00:00Z 2016 3     2016-03-07T16:33:18Z   0 0 0900006481e9da81

Links from other tables

  • 0 rows from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 39.004ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API